Carregant...
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
CONTEXT: Canagliflozin is a sodium glucose cotransporter 2 inhibitor developed to treat type 2 diabetes mellitus (T2DM). OBJECTIVE: The purpose of this study was to describe the effects of canagliflozin on bone fracture risk. DESIGN AND SETTING: This was a randomized phase 3 study in patients with T...
Guardat en:
| Publicat a: | J Clin Endocrinol Metab |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4701850/ https://ncbi.nlm.nih.gov/pubmed/26580237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-3167 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|